Cargando…
Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging
The amyloid cascade hypothesis provides an economical mechanistic explanation for Alzheimer's disease (AD) dementia and correlated neuropathology. However, some nonagenarian individuals (high pathology controls, HPC) remain cognitively intact while enduring high amyloid plaque loads for decades...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210154/ https://www.ncbi.nlm.nih.gov/pubmed/22087282 http://dx.doi.org/10.1371/journal.pone.0027291 |
_version_ | 1782215717126406144 |
---|---|
author | Maarouf, Chera L. Daugs, Ian D. Kokjohn, Tyler A. Walker, Douglas G. Hunter, Jesse M. Kruchowsky, Jane C. Woltjer, Randy Kaye, Jeffrey Castaño, Eduardo M. Sabbagh, Marwan N. Beach, Thomas G. Roher, Alex E. |
author_facet | Maarouf, Chera L. Daugs, Ian D. Kokjohn, Tyler A. Walker, Douglas G. Hunter, Jesse M. Kruchowsky, Jane C. Woltjer, Randy Kaye, Jeffrey Castaño, Eduardo M. Sabbagh, Marwan N. Beach, Thomas G. Roher, Alex E. |
author_sort | Maarouf, Chera L. |
collection | PubMed |
description | The amyloid cascade hypothesis provides an economical mechanistic explanation for Alzheimer's disease (AD) dementia and correlated neuropathology. However, some nonagenarian individuals (high pathology controls, HPC) remain cognitively intact while enduring high amyloid plaque loads for decades. If amyloid accumulation is the prime instigator of neurotoxicity and dementia, specific protective mechanisms must enable these HPC to evade cognitive decline. We evaluated the neuropathological and biochemical differences existing between non-demented (ND)-HPC and an age-matched cohort with AD dementia. The ND-HPC selected for our study were clinically assessed as ND and possessed high amyloid plaque burdens. ELISA and Western blot analyses were used to quantify a group of proteins related to APP/Aβ/tau metabolism and other neurotrophic and inflammation-related molecules that have been found to be altered in neurodegenerative disorders and are pivotal to brain homeostasis and mental health. The molecules assumed to be critical in AD dementia, such as soluble or insoluble Aβ40, Aβ42 and tau were quantified by ELISA. Interestingly, only Aβ42 demonstrated a significant increase in ND-HPC when compared to the AD group. The vascular amyloid load which was not used in the selection of cases, was on the average almost 2-fold greater in AD than the ND-HPC, suggesting that a higher degree of microvascular dysfunction and perfusion compromise was present in the demented cohort. Neurofibrillary tangles were less frequent in the frontal cortices of ND-HPC. Biochemical findings included elevated vascular endothelial growth factor, apolipoprotein E and the neuroprotective factor S100B in ND-HPC, while anti-angiogenic pigment epithelium derived factor levels were lower. The lack of clear Aβ-related pathological/biochemical demarcation between AD and ND-HPC suggests that in addition to amyloid plaques other factors, such as neurofibrillary tangle density and vascular integrity, must play important roles in cognitive failure. |
format | Online Article Text |
id | pubmed-3210154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-32101542011-11-15 Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging Maarouf, Chera L. Daugs, Ian D. Kokjohn, Tyler A. Walker, Douglas G. Hunter, Jesse M. Kruchowsky, Jane C. Woltjer, Randy Kaye, Jeffrey Castaño, Eduardo M. Sabbagh, Marwan N. Beach, Thomas G. Roher, Alex E. PLoS One Research Article The amyloid cascade hypothesis provides an economical mechanistic explanation for Alzheimer's disease (AD) dementia and correlated neuropathology. However, some nonagenarian individuals (high pathology controls, HPC) remain cognitively intact while enduring high amyloid plaque loads for decades. If amyloid accumulation is the prime instigator of neurotoxicity and dementia, specific protective mechanisms must enable these HPC to evade cognitive decline. We evaluated the neuropathological and biochemical differences existing between non-demented (ND)-HPC and an age-matched cohort with AD dementia. The ND-HPC selected for our study were clinically assessed as ND and possessed high amyloid plaque burdens. ELISA and Western blot analyses were used to quantify a group of proteins related to APP/Aβ/tau metabolism and other neurotrophic and inflammation-related molecules that have been found to be altered in neurodegenerative disorders and are pivotal to brain homeostasis and mental health. The molecules assumed to be critical in AD dementia, such as soluble or insoluble Aβ40, Aβ42 and tau were quantified by ELISA. Interestingly, only Aβ42 demonstrated a significant increase in ND-HPC when compared to the AD group. The vascular amyloid load which was not used in the selection of cases, was on the average almost 2-fold greater in AD than the ND-HPC, suggesting that a higher degree of microvascular dysfunction and perfusion compromise was present in the demented cohort. Neurofibrillary tangles were less frequent in the frontal cortices of ND-HPC. Biochemical findings included elevated vascular endothelial growth factor, apolipoprotein E and the neuroprotective factor S100B in ND-HPC, while anti-angiogenic pigment epithelium derived factor levels were lower. The lack of clear Aβ-related pathological/biochemical demarcation between AD and ND-HPC suggests that in addition to amyloid plaques other factors, such as neurofibrillary tangle density and vascular integrity, must play important roles in cognitive failure. Public Library of Science 2011-11-07 /pmc/articles/PMC3210154/ /pubmed/22087282 http://dx.doi.org/10.1371/journal.pone.0027291 Text en Maarouf et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Maarouf, Chera L. Daugs, Ian D. Kokjohn, Tyler A. Walker, Douglas G. Hunter, Jesse M. Kruchowsky, Jane C. Woltjer, Randy Kaye, Jeffrey Castaño, Eduardo M. Sabbagh, Marwan N. Beach, Thomas G. Roher, Alex E. Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging |
title | Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging |
title_full | Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging |
title_fullStr | Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging |
title_full_unstemmed | Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging |
title_short | Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging |
title_sort | alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210154/ https://www.ncbi.nlm.nih.gov/pubmed/22087282 http://dx.doi.org/10.1371/journal.pone.0027291 |
work_keys_str_mv | AT maaroufcheral alzheimersdiseaseandnondementedhighpathologycontrolnonagenarianscomparingandcontrastingthebiochemistryofcognitivelysuccessfulaging AT daugsiand alzheimersdiseaseandnondementedhighpathologycontrolnonagenarianscomparingandcontrastingthebiochemistryofcognitivelysuccessfulaging AT kokjohntylera alzheimersdiseaseandnondementedhighpathologycontrolnonagenarianscomparingandcontrastingthebiochemistryofcognitivelysuccessfulaging AT walkerdouglasg alzheimersdiseaseandnondementedhighpathologycontrolnonagenarianscomparingandcontrastingthebiochemistryofcognitivelysuccessfulaging AT hunterjessem alzheimersdiseaseandnondementedhighpathologycontrolnonagenarianscomparingandcontrastingthebiochemistryofcognitivelysuccessfulaging AT kruchowskyjanec alzheimersdiseaseandnondementedhighpathologycontrolnonagenarianscomparingandcontrastingthebiochemistryofcognitivelysuccessfulaging AT woltjerrandy alzheimersdiseaseandnondementedhighpathologycontrolnonagenarianscomparingandcontrastingthebiochemistryofcognitivelysuccessfulaging AT kayejeffrey alzheimersdiseaseandnondementedhighpathologycontrolnonagenarianscomparingandcontrastingthebiochemistryofcognitivelysuccessfulaging AT castanoeduardom alzheimersdiseaseandnondementedhighpathologycontrolnonagenarianscomparingandcontrastingthebiochemistryofcognitivelysuccessfulaging AT sabbaghmarwann alzheimersdiseaseandnondementedhighpathologycontrolnonagenarianscomparingandcontrastingthebiochemistryofcognitivelysuccessfulaging AT beachthomasg alzheimersdiseaseandnondementedhighpathologycontrolnonagenarianscomparingandcontrastingthebiochemistryofcognitivelysuccessfulaging AT roheralexe alzheimersdiseaseandnondementedhighpathologycontrolnonagenarianscomparingandcontrastingthebiochemistryofcognitivelysuccessfulaging |